MARIA ALEXOUDIS: Open Payments
NPI 1144976606 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 18 payments from 10 companies in 2025. Trend: 2023 $464 · 2024 $162 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 3 | $199 |
| Fresenius USA Marketing, Inc. | 1 | $96 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Amgen Inc. | 2 | $47 |
| AKEBIA THERAPEUTICS INC | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Novo Nordisk Inc | 1 | $28 |
| Travere Therapeutics, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Alexion Pharmaceuticals, Inc. | 1 | $19 |
Products named: TARPEYO, VELPHORO, FARXIGA, Vafseo, Ozempic, TAVNEOS, KRYSTEXXA, Kerendia.
Industry payments across NC — which companies pay providers there.
